2-{2-[3-(4-bromophenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[3-(4-bromophenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[3-(4-bromophenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | E239-0190 |
Compound Name: | 2-{2-[3-(4-bromophenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 547.47 |
Molecular Formula: | C27 H23 Br N4 O2 S |
Smiles: | Cc1ccc(cc1)C1CC(c2ccc(cc2)[Br])=NN1C1=NC(C(CC(Nc2ccccc2)=O)S1)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 6.0752 |
logD: | 6.0752 |
logSw: | -5.6309 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 58.972 |
InChI Key: | MJJOVMOOBUGYJL-UHFFFAOYSA-N |